Tony DeSpirito joins host Oscar Pulido to help make sense of recent market turmoil from an equity perspective.

US President Donald Trump’s whirlwind visit last week to the Middle East saw a wave of AI dealmaking that could reshape the ...

Emerging market equity funds are leading the global performance this year, bolstered by attractive valuations, years of under ...

NEW YORK, United States - Wall Street stocks finished a meandering session higher Monday, shrugging off Moody's downgrade of ...

Apollo Global Management (NYSE:APO) recently secured a significant $975 million debt funding, which includes support from firms like Brookfield and Blackstone. This financial bolstering may have ...

The Africa of 2025 has something for every global investor, despite global market turbulence and uncertainty, including ...

Halliburton (NYSE:HAL) recently declared a second-quarter dividend of $0.17 per share, scheduled for payment on June 25, 2025, which highlights the company's commitment to returning value to its ...

Comparing the US Tech 100 and the UK tech scene highlights their strengths and weaknesses. The US market thrives on scale and ...

Market is expected to witness a CAGR of 5% by 2029. The key factors driving the pharma CCO market growth are growing R&D ...

For April, the Global Light Vehicle (LV) selling rate is estimated to be 92 million units/year, reports GlobalData.

The US market continues to dominate other markets in telemedicine-related fundraising, with more than 2,472 deals completed between 2015 and 2024, according to a new report from Drake Star.

BMO Capital analyst Evan Seigerman maintained a Buy rating on Pfizer Inc. (NYSE:PFE) and kept the price target the same at $30. The reiteration comes after the company recently announced entering into ...